In Copyright (se abre en una nueva ventana)

Effect of genetic variants of the ABCC2 transporter on bioavailability of mycophenolic acid in renal-transplant patients

Mycophenolic acid (MPA) displays variable pharmacokinetics (PK). It is metabolized by UGTs to MPA-glucuronide which is subject to enterohepatic recirculation. Biliary and kidney excretion involves multidrug resistant protein 2 (MRP2) coded by ABCC2. We assessed steady-state PK of MPA in renal allograft recipients in respect to donor and recipient ABCC2 genotypes, along with other clinical covariat…

Ver en el sitio web del proveedor de datos (se abre en una nueva ventana)

Contribuyentes

  • Božina, Nada

Creador

  • Lalić, Zdenka

Editor

  • University of Zagreb. Faculty of Pharmacy and Biochemistry.

Asunto

  • BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy.
  • Biotechnology. Genetic engineering. Products of cloning
  • mycophenolic acid
  • pharmacokinetics
  • pharmacogenetics
  • MRP2/ABCC2
  • renal transplant patients
  • cyclosporine
  • tacrolimus

Tipo de ítem

  • info:eu-repo/semantics/doctoralThesis
  • text

Fecha

  • 2015-12-03
  • 2015-12-03